The attachment sites of lower extremity bypass grafts are known to exhibit a wide range of geometries. Factors that determine the geometry of a given anastomosis include graft material, graft site, native vessel size, graft size and individual patient anatomy. Therefore, it is difficult to specify a standard anastomosis geometry before surgery and difficult to predict the effect of the geometry on long-term graft patency. We have used 3-D ultrasound imaging to study 46 proximal anastomoses of lower limb bypass grafts. We have developed methods to characterize the 3-D geometry of the anastomosis in terms of component sizes and angles. These detailed geometric measurements describe a range of anastomosis geometries and establish standardized parameters across cases that can be used to relate anastomosis geometry to outcome.
A method has been developed to display Doppler spectral waveforms in lower extremity vein grafts in conjunction with 3-D vessel geometry. Doppler spectral waveforms and cross-sectional images of the vein graft are collected with a custom 3-D ultrasound imaging system. Computer processing generates a display of the Doppler sample volumes registered in 3-D space with a surface reconstruction of the vein graft lumen. An interactive computer interface displays spectral waveforms at user-selected sites in the graft. Summary displays combining spectral waveforms, maximum velocity and cross-sectional area provide a pictorial record of the state of the vein graft along its full length. The method is demonstrated for two patient studies, each at two time points after graft revisions. The graphic display of both hemodynamics and geometry allows rapid assessment of vein graft changes over time.
AIM:Although recanalization occurs after an episode of venous thrombosis, the exact timing for this process, the rate of clearing at the different venous segments and the nature of the mechanisms involved and their progression are not well known. Recognition of these competing events is important in understanding the natural history and the mechanisms responsible for lysis of the thrombus and for the development of the post-thrombotic syndromeMETHODS:During the course of 5 consecutive years, 110 patients (126 legs) with deep vein thrombosis (DVT) were prospectively followed using ultrasonic duplex. Follow-up studies were performed at intervals of 1 and 7 days, 1 month, every 3 months for the 1(st) year, and yearly thereafter. Mean duration of follow-up was 329 days.RESULTS:When only legs with initial complete occlusion are considered, the prevalence of occlusion progressively decreases to 33% after 6 months, 17% after the 1(st) year, and 0% after 3 years. Recanalization of individual segments occurred even more rapidly. After 3 months, recanalization of completely occluded segments was present in 93% of common femoral veins, 79% of superficial femoral veins (proximal segment), 84% of popliteal veins, and 72% of posterior tibial veins. The rate of recanalization was highest for multisegmental disease. Propagation of thrombi to adjacent venous segments occurred in 15% of the limbs. Propagation was usually limited to 1 or 2 adjacent segments.CONCLUSION:Lysis occurred early and was progressive. After 1 year most legs have recanalized. After 3 years recanalization occurred in all legs although residual thrombosis (partial obstruction) was still present in 50% of the limbs. Propagation of the thrombus was a limited process.
OBJECTIVE:Remodeling of vein grafts in the lower limb can lead to stenotic lesions that threaten long-term graft patency. Progressive changes in vein graft geometry were measured at sites of repaired stenoses with three-dimensional (3D) ultrasound imaging.METHODS:Ten vein graft revisions with patch angioplasty were followed up for 31 to 47 weeks. Four revisions were at valve sites, and six were at sites of diffuse intimal hyperplasia. Sets of spatially registered two-dimensional (2D) cross-sectional ultrasound images were assembled to create 3D computer models of each vein graft. Cross-sectional area measurements in planes normal to the vessel center axis were calculated from the 3D surface reconstructions. Data sets from serial studies were registered in a common coordinate system, and cross-sectional area measurements were compared at matched sites.RESULTS:Three of the four vein graft revisions at valve sites changed by less than 18%, and one decreased in cross-sectional area by 61%. Five of the six revisions at sites of diffuse intimal hyperplasia demonstrated significant decreases in lumen area ranging from 26% to 61%, and one revision exhibited no significant change in cross-sectional area. Reproducibility of the cross-sectional area measurements derived from the 3D imaging technique was 6.9%.CONCLUSIONS:Sequential area measurements from 3D ultrasound scans demonstrated different remodeling patterns and rates of change among revision sites within the vein grafts. Lumen narrowing documented with 3D scanning was not associated with consistent flow velocity changes on conventional duplex graft surveillance scans.
OBJECTIVERecanalization is common after acute deep venous thrombosis, but the factors that contribute to its variable extent are unknown. The purpose of this study was to examine the relationship between recanalization and plasma markers of coagulation and fibrinolysis.METHODSSubjects with an ultrasound-confirmed deep venous thrombosis had prothrombin fragment 1+2 (F 1+2), tissue plasminogen activator (t-PA) activity, plasminogen activator inhibitor (PAI-1) activity, and t-PA antigen levels determined before anticoagulation therapy. Ultrasound and plasma studies were repeated at 14 days, 1 month, and every 3 months for 1 year.RESULTSAmong 71 enrolled subjects, F 1+2 levels normalized within 14 days. The mean t-PA activity was within the normal range at all follow-up intervals. However, the mean t-PA antigen (10.7 plus minus 10.5 to 13.6 plus minus 13.5 ng/mL; P =.04) and PAI-1 (9.0 plus minus 8.1 to 13.2 plus minus 17.3 U/mL; P =.05) levels increased between the time of presentation and day 14. The mean reduction in thrombus score among 44 patients who completed 9 months of follow-up was 60.9% (plus minus 42.1%). Percent recanalization was directly associated with initial t-PA activity levels (R =.4; P =.006) and inversely related to F 1+2 (R = minus sign. 5; P =.004), t-PA antigen (R = minus sign.5, P =.002), and PAI-1 (r = minus sign. 5, P =.001) levels. However, only initial F 1+2 (P =.0009) and t-PA antigen (P =.004) levels were independent predictors of the degree of recanalization.CONCLUSIONAlthough the mechanisms by which the venous lumen is restored are still being elucidated, recanalization is inversely related to levels of activated coagulation (F 1+2) and fibrinolytic inhibition (t-PA antigen) at the time of presentation.
Frequent surveillance of bypass grafts placed in the lower limbs can provide early detection of stenoses. A three-dimensional (3-D) ultrasound (US) imaging system has been used to produce serial surface reconstructions of regions of interest in vein grafts in the lower extremities. Using anatomical reference points, data sets from serial studies are registered in a common 3-D coordinate system. Cross-sectional area measurements are extracted from the surface reconstructions in planes normal to the vessel center axis. These measurements are compared at matched sites over time to track changes in the vessel configuration. The quantitative measurements are paired with surface displays of the vessels for a complete depiction of the changing geometry. Example studies from three patients are shown, for time periods up to 38 weeks. The cross-sectional area measurements highlight regions of remodeling and developing stenoses within the grafts. (E-mail: leotta@u.washington.edu) (C) 2001 World Federation for Ultrasound in Medicine & Biology.
PURPOSE:The objectives of this study were to describe the venous valves and determine their fate over time in reversed saphenous vein (RSV) and in situ saphenous vein (ISV) bypass grafts with duplex ultrasonography.METHODS:Sixty-four patients contributed 50 RSV and 19 ISV infrainguinal vein grafts. Forty-two of the RSVs and 17 of the ISVs had valves or valve remnants. The grafts and valves were studied serially with duplex ultrasonography to document the location, characteristics, and changes with time. The valve leaflets visualized by means of ultrasonic duplex scanning were described as moving, frozen, remnant of a cusp, or "functioning." In addition, the presence of a valve sinus and thickening of the wall at the site were documented. Grafts were studied at 1, 2, 3, 4, 6, 9, 12, and 18 months and then annually.RESULTS:In 42 RSV grafts (84%) and 17 ISV grafts (89.5%), 200 valves were identified. Only five of the 200 valves (2.5%) required intervention because of a velocity ratio (VR) of 3.5 or greater. Eight (42.1%) of the 19 ISV grafts needed 15 revisions, and 18 (36%) of the 50 RSV grafts required 30 revisions. The five revisions for a stenotic valve occurred only in RSV grafts. From the 30 revisions in the RSV grafts, only 16.7% (5 of 30) were for a valve-related stenosis. The average follow-up period for a valve from the time of detection was 16.1 +/- 9.6 months. Ten of the 17 (58.8%) valve-associated stenoses (VR > 2.5) showed a regression to a VR less than 2.0 within a mean time of 3.1 months (range, 1.5-4.5 months). A progression of the valve-associated lesion from a VR less than 2.0 to a VR higher than 3.5 occurred in only one case within a period of 3.5 months.CONCLUSION:The described features of valves in saphenous vein grafts are common and can be identified by means of duplex sonography. Only 16.7% of the revisions in RSV grafts were performed because of a valve-related stenosis, and none of the revisions in ISV grafts were performed because of a valve lesion. Lesions associated with a valve may regress in time. No specific valve features could be identified as "high" risk for graft failure.
OBJECTIVE:The objective of this study was to assess the prognostic value of hemodynamic parameters measured with duplex ultrasound scan, together with other important graft and patient characteristics, in predicting lower extremity vein graft thrombosis.METHODS:A total of 165 lower extremity vein grafts were entered prospectively into a postoperative duplex ultrasound scan surveillance program with examinations performed at 1, 2, 3, 4, 6, 9, 12, 18, and 24 months, and annually thereafter. Duplex scan-derived blood flow velocity measurements were recorded at 1562 patient visits over 7 years. Graft patency was determined after each visit, and an analysis of factors predictive of vein graft thrombosis was performed with Poisson regression.RESULTS:Thirty-two episodes of first-time graft thrombosis occurred, 23 of which were permanent. One-, 3-, and 5-year secondary graft patency rates were 90%, 86%, and 79%, respectively. In multivariate analyses, duplex scan velocity measurements predictive of lower extremity graft thrombosis included the maximum velocity ratio (Vr) in association with a graft stenosis and the mean graft peak systolic velocity (MGV) within nonstenotic portions of the body of the graft. The incidence of graft thrombosis among grafts without inflow/outflow stenoses, with Vr less than 3.5, and with MGV 50 cm/s or more, was 2.9% per year. Incidence rates were considerably higher among grafts with a of Vr of 3.5 or more (incidence rate ratio = 7.0; 95% CI, 3.4-14.6) or an MGV less than 50 cm/s (incidence rate ratio = 6.5; 95% CI, 3.3-13.1). In grafts without identifiable inflow, outflow, or graft stenoses, there was no association between MGV and the risk of graft thrombosis.CONCLUSION:Duplex scan velocity measurements are valid predictors of impending graft thrombosis. A Vr of 3.5 or more and an MGV less than 50 cm/s are the best predictive measures. Repair of correctable graft lesions with a Vr of 3.5 or more, or inflow, outflow, or graft lesions associated with an MGV less than 50 cm/s are recommended. Grafts without detectable inflow, outflow, or graft stenoses, regardless of MGV, may be safely followed.
OBJECTIVE:Plasma markers of coagulation and fibrinolysis have proved sensitive in the initial diagnosis of acute deep venous thrombosis (DVT). The purpose of this study was to examine the evolution and utility of measuring D-dimer and prothrombin fragment 1+2 (F 1+2) levels after an acute DVT.METHODS:Subjects with DVT confirmed by ultrasonography had quantitative plasma D-dimer and F 1+2 levels determined before anticoagulation. Ultrasound scan and coagulation studies were repeated at 3, 7, and 14 days; 1 month; and every 3 months for 1 year.RESULTS:Sixty-one patients with a median initial thrombus score of 3 (interquartile range, 2-7) were followed up for 266 days (interquartile range, 91.5-364 days). Initial D-dimer levels were elevated in 92.7% of patients and were associated with thrombus extent (P =.003), whereas F 1+2 levels were increased in 94.5% of patients and were lower in patients with isolated calf vein thrombosis (P =.001). Initial D-dimer (P =.002) and F 1+2 levels (P =.009) were significantly higher in the 26 (43%) patients with recurrent thrombosis during follow-up. Initial D-dimer levels of 2000 ng/mL or greater were predictive of recurrent events after both proximal and isolated calf vein thrombosis. Although interval increases in these markers had little value in detecting recurrent thrombotic events, D-dimer levels of 1000 ng/mL or greater and 500 ng/mL or greater had respective sensitivities of 89.3% and 100% in detecting early and late recurrences. Corresponding specificities were 35.6% and 53.9%.CONCLUSIONS:Initial D-dimer levels are determined by total thrombus load and remain elevated long after an acute DVT. F 1+2 levels are less sensitive to thrombus score and return to baseline more quickly. Initial levels of these markers may have some utility in predicting the risk of ultrasound scan-documented recurrences, whereas increased D-dimer levels are a sensitive but nonspecific marker of these events.
Vein grafts are placed to bypass diseased arteries in the lower limb when symptoms such as pain during walking, rest pain, and tissue necrosis occur. Frequent surveillance of these grafts is recommended since early detection and revision of stenoses improves the likelihood of long-term patency. We are using three-dimensional (3D) ultrasound imaging to measure progressive changes in vein graft geometry. Cross-sectional area measurements in planes normal to the vessel center axis are calculated from 3D surface reconstructions. Data sets from serial studies are registered in a common coordinate system using anatomical reference points and cross-sectional area measurements are compared at matched sites. Extended studies have tracked patients requiring surgical revision to enlarge the vessel lumen in stenotic regions of their grafts. Follow-up periods on 5 cases range from 30 to 79 weeks to date. Each revised graft segment demonstrated a decrease in cross-sectional area over time, ranging from 25% to 77%, averaged over the length of the revision. The sequential area measurements, combined with 3D surface displays, provide a record of remodeling patterns and rates at specific sites within the grafts.
The relationship between atherosclerotic renal artery stenosis (ARAS) and blood pressure control remains poorly understood. Duplex ultrasonography is a noninvasive method for detecting and grading ARAS. The purpose of this study was to characterize the relationship between the degree of ARAS, levels of blood pressure, and control of blood pressure with antihypertensive medication. A cross-sectional analysis was performed on 139 patients with ARAS. All patients had at least one diseased renal artery by duplex ultrasound. Renal arteries were classified as normal, less than 60% stenosis, or 60% or greater (high-grade) stenosis. Data regarding blood pressure, coexisting risk factors, and medications were collected. The extent of ARAS was significantly associated with progressive elevation of the systolic blood pressure, whereas the diastolic component was elevated in the case of unilateral high-grade stenosis: no high-grade stenoses, 153 +/- 22/81 +/- 10 mm Hg; unilateral high-grade stenosis, 162 +/- 22/86 +/- 9 mm Hg; and bilateral high-grade stenoses, 174 +/- 27/82 +/- 9 mm Hg (P = 0.002 systolic; P = 0.02 diastolic). Eighty-two percent of the patients were taking known antihypertensive medications. Angiotensin-converting enzyme inhibitor (ACEI) usage versus nonusage was associated with a significantly lower systolic (157 +/- 27 v169 +/- 22 mm Hg; P = 0.03) and diastolic (79 +/- 9 v 85 +/- 9 mm Hg; P = 0.001) blood pressure. The effect of ACEI usage was observed in patients with high-grade ARAS. None of the other classes of antihypertensive medications were associated with significantly lower blood pressure. In patients with ARAS, blood pressure levels were correlated with the severity of renal artery disease. Patients taking ACEIs had significantly lower blood pressures, and the effect of ACEI usage was strongest among patients with unilateral ARAS.
Purpose: The purpose of this investigation was to evaluate the relationship between the presenting features of an acute deep venous thrombosis (DVT), the subsequent natural history of the thrombus, and the ultimate outcome as defined according to the Society for Vascular Surgery and the North American Chapter of the International Society for Cardiovascular Surgery reporting standards in venous disease. Methods: Patients with an acute DVT were followed with serial clinical and ultrasound examinations. Thrombus extent within 7 venous segments was scored retrospectively according to the reporting standards (scores ranged from 0 to 3), and segmental reflux was scored as present (1) or not present (0). The initial and final thrombus scores, the rates of recanalization and rethrombosis, and the total reflux scores were then calculated from these grading scales and related to ultimate chronic venous disease (CVD) classification. Results: Sixty-eight patients with an acute DVT in 73 limbs were followed for 18 to 110 months (mean, 55 ± 26 months). At the completion of the follow-up period, 20 extremities (27%) were asymptomatic (class 0), 13 (18%) had pain or prominent superficial veins (class 1), 25 (34%) had manifested edema (class 3), 13 (18%) had developed hyperpigmentation (class 4), and 2 (3%) had developed ulceration (class 5). In a univariate analysis, CVD classification was correlated with the reflux score (P = .003) but not with the initial or final thrombus score or with the rate of recanalization or rethrombosis. In a multivariate model of features documented at presentation, only the tibial thrombosis score was a significant predictor of CVD classification (R2 = .06). Outcome was better predicted (R2 = .29) with a model that included variables defined during follow-up—the final reflux score, the final popliteal score, and the rate of recanalization. Conclusion: The ability to predict the severity of CVD after an acute DVT is currently limited, although the natural history appears more important than the presenting features of the event. The extent of reflux, the presence of persistent popliteal obstruction, and the rate of recanalization are related to ultimate CVD classification, but other determinants remain to be identified. (J Vasc Surg 1998;28:826-33.)
Background: Atherosclerotic lesions of the carotid and lower extremity arteries may be associated with renal artery stenosis and influence the management of patients with renal artery disease.Objective: To document the prevalence and clinical features of carotid and lower extremity arterial disease in patients with renal artery atherosclerosis.Methods: An analysis of baseline data on 149 patients enrolled in a prospective natural history study of atherosclerotic renal artery stenosis. Patients with at least 1 abnormal renal artery by duplex scanning were eligible. Carotid artery disease was evaluated by duplex scanning, and ankle/brachial indices were used to assess the lower extremity arteries. Disease at each of the 3 arterial sites was classified as mild, moderate, or severe based on the extent of involvement on both sides. Serum urea nitrogen, creatinine, and lipid levels were also measured.Results: Severe renal, carotid, or lower extremity arterial disease was present in 44%, 19%, and 21% of the patients, respectively. There was a trend for patients with increasing degrees of renal artery disease to have increasing degrees of carotid and lower extremity arterial disease. The prevalence of severe carotid artery disease increased from 7% in the mild renal artery group to 28% in the severe renal artery group. Clinical factors that were most predictive of severe disease were elevated apolipoprotein B levels for the renal arteries, high serum urea nitrogen or creatinine levels for the carotid arteries, and smoking for the lower extremity arteries.Conclusions: There was a strong association between severe renal artery atherosclerosis and severe carotid artery disease. Patients with renal artery disease also had a high prevalence of lower extremity arterial disease. In this patient population, screening for lower extremity arterial disease can be reserved for those with signs or symptoms of peripheral ischemia. Noninvasive carotid screening is justified in patients with renal artery disease to detect asymptomatic lesions that require either immediate surgical treatment or serial follow-up for disease progression.
A severe arterial occlusion in the leg usually is bypassed by implanting a saphenous vein harvested from the limb. Once implanted, the vein functions well but over time may develop stenoses that may lead to occlusion. In order to detect and correct the stenoses that may lead to graft failure, frequent surveillance of the vein graft is required. A new ultrasound imaging method was developed to display the panoramic view of the vein graft in combination with its blood flow velocity waveform for surveillance. The panoramic view is the projection (ray-casting) image of multiple B-mode images with sequential longitudinal view of the vein graft. The velocity waveform also is recorded along the vessel with pulsed Doppler ultrasound. The acquired images and waveforms from the ultrasound scanner are registered individually in three-dimensional space with an electromagnet-based position and orientation sensor located on the scanhead. A prominent point on the scar from the surgery is used as the fiducial mark for spatial registration, so that the same lesion in the vein graft can be tracked automatically at each visit for retrospective study.
BACKGROUND:The aim of this study was to determine the incidence of and the risk factors associated with progression of renal artery disease in individuals with atherosclerotic renal artery stenosis (ARAS). METHODS AND RESULTS:Subjects with >/=1 ARAS were monitored with serial renal artery duplex scans. A total of 295 kidneys in 170 patients were monitored for a mean of 33 months. Overall, the cumulative incidence of ARAS progression was 35% at 3 years and 51% at 5 years. The 3-year cumulative incidence of renal artery disease progression stratified by baseline disease classification was 18%, 28%, and 49% for renal arteries initially classified as normal, <60% stenosis, and >/=60% stenosis, respectively (P=0.03, log-rank test). There were only 9 renal artery occlusions during the study, all of which occurred in renal arteries having >/=60% stenosis at the examination before the detection of occlusion. A stepwise Cox proportional hazards model included 4 baseline factors that were significantly associated with the risk of renal artery disease progression during follow-up: systolic blood pressure >/=160 mm Hg (relative risk [RR]=2.1; 95% CI, 1.2 to 3.5), diabetes mellitus (RR=2.0; 95% CI, 1.2 to 3.3), and high-grade (>60% stenosis or occlusion) disease in either the ipsilateral (RR=1.9; 95% CI, 1.2 to 3.0) or contralateral (RR=1.7; 95% CI, 1.0 to 2.8) renal artery. CONCLUSIONS:Although renal artery disease progression is a frequent occurrence, progression to total renal artery occlusion is not. The risk of renal artery disease progression is highest among individuals with preexisting high-grade stenosis in either renal artery, elevated systolic blood pressure, and diabetes mellitus.
Purpose: The short and long-term anatomic results of percutaneous transluminal renal angioplasty (PTRA) in the treatment of atherosclerotic renovascular disease have been poorly documented because of a lack of follow-up arteriography. The purpose of this study was to evaluate the anatomic results of PTRA with serial duplex examinations.Methods: The records of 41 patients who underwent 52 primary PTRA procedures and had subsequent duplex follow-up of at least 6 months were reviewed. After PTRA, renal arteries were classified as normal, <60% stenosis, greater than or equal to 60% stenosis, or occluded on the basis of previously validated duplex criteria.Results: The study group included 26 men and 15 women with a mean age of 65 years, who were observed for a mean interval of 34 months. Endovascular stents were placed in 12 of the 52 arteries. The initial post-PTRA. renal artery stenosis classification (based on arteriography or duplex scan) was normal in 23, <60% in 19, and greater than or equal to 60% in 10. The cumulative incidence of restenosis from normal to greater than or equal to 60% was 13% at 1 year and 19% at 2 years. The cumulative incidence of restenosis from <60% to greater than or equal to 60% to was 44% at 1 year and 55% at 2 years. The cumulative incidence of progression from greater than or equal to 60% to occlusion was 10% at 2 years. Although 83% of the 12 stented arteries and only 33% of the 40 nonstented arteries were normal immediately after PTRA, after 1 year the stented renal arteries showed a 44% restenosis rate, whereas the nonstented renal arteries showed a 18% restenosis rate (p=0.087).Conclusions: Restenosis after PTRA. for atherosclerotic disease is relatively common and correlates with the initial anatomic result Although PTRA with stent placement yields superior immediate technical results, the high early restenosis rate is disturbing.
Purpose: The clinical significance of isolated calf vein thrombosis (CVT), particularly with respect to development of the postthrombotic syndrome, remains controversial. The purpose of this study was to define the early natural history of CVT in relation to persistent lower extremity symptoms, propagation, recanalization, and the development of valvular incompetence.Methods: Over a 116-month period, 499 patients with acute deep venous thrombosis (DVT) were referred to our research laboratory, of whom 58 (12%) had thrombosis confined to the calf veins of at least one extremity. The lower extremities of 268 patients (29 with isolated CVT) were followed-up clinically and with duplex ultrasonography at intervals of 1 day, 7 days, 1 month, every 3 months for the first year, and yearly thereafter.Results: Seventy percent of extremities with CVT were symptomatic at presentation. Although the prevalence of clinical signs and symptoms decreased to 29% by 1 month, 23% of patients had persistent pain, edema, or both at 12 months. In contrast, 9% of uninvolved extremities contralateral to a CVT and 54% of extremities with proximal DVT remained symptomatic at 1 year (p = 0.004). Recanalization proceeded rapidly such that the mean thrombus load was reduced by 50% at 1 month and to zero at 1 year. The prevalence of valvular incompetence progressively increased such that reflux was present in 24% of extremities at 1 year. Although its investigation was not a primary goal of this study, pulmonary embolism was diagnosed at presentation and during follow-up in 11% and 3% of patients, respectively.Conclusions: The natural history of CVT is complicated by persistent symptoms and the development of valvular incompetence in approximately one-quarter of patients. This potential for persistent lower extremity symptoms should be considered in evaluating the clinical relevance of isolated calf vein DVT.
Two major sequelae of deep vein thrombosis (DVT), obstruction to outflow due to the presence of residual thrombus and reflux due to valvular damage, may contribute to the development of the post-thrombotic syndrome (PTS). We studied the nature and site of residual abnormality, non-invasively with duplex ultrasound, in the veins of 69 limbs in 66 patients, 1 to 6 years after primary acute DVT. There were clinical features of the PTS in 27 limbs and 42 legs were asymptomatic. The pattern of duplex abnormalities was complex and varied for both the PTS and asymptomatic groups. The proportion of abnormal common and external iliac veins and abnormal common, deep and superficial femoral veins was similar for limbs with the PTS and asymptomatic limbs. Twenty-six per cent of legs with the PTS had reflux at the saphenofemoral junction compared with 19% asymptomatic legs (difference not significant). The PTS was associated with proportionally more abnormal popliteal veins (81% vs 55%) and posterior tibial veins (PTV), PTV#1 (41% vs 21%) and PTV#2 (41% vs 14%) when compared with asymptomatic limbs. THe odds ratio for a popliteal vein abnormality being associated with the PTS was 3.63 (95% CI 1.16 to 11.43). The odds ratios for PTV#1 and PTV#2 abnormalities in association with the PTS compared to asymptomatic limbs were 2.52 (95% CI 0.87 to 7.31) and 4.13 (95% CI 1.30 to 13.11). In conclusion, residual venous abnormalities after DVT are common and when present in the popliteal and tibial veins are associated with an increased likelihood of PTS expression.
The natural history of renal artery stenosis (RAS) has been difficult to document because serial arteriography is rarely justified. Duplex scanning is a noninvasive technique that is ideally suited for both screening and follow-up of RAS. In this approach, renal arteries are classified as normal, <60% stenosis, ≥60% stenosis, or occluded, and disease progression is defined as a change in the duplex classification. The purpose of this study was to determine the rate of disease progression in atherosclerotic RAS by serial duplex scanning. At least one abnormal renal artery was identified in each of 76 patients being screened for RAS. Of the 152 renal arteries, 20 were excluded (14 prior interventions, 5 occlusions, 1 technically inadequate duplex scan), leaving 132 for the natural history follow-up protocol. The patient group included 36 men and 40 women, with a mean age of 67 years, who were followed for a mean of 32 months (maximum 55 months). The initial status of the 132 renal arteries was normal in 36, < 60% stenosis in 35, and ≥ 60% stenosis in 61. The cumulative incidence of progression from normal to ≥ 60% RAS was 0% at 1 year, 0% at 2 years, and 8% at 3 years. The cumulative incidence of progression from < 60% to ≥ 60% RAS was 30% at 1 year, 44% at 2 years, and 48% at 3 years. All 4 renal arteries that progressed to occlusion had ≥ 60% stenoses at the initial visit and for those arteries with a ≥ 60% stenosis, the cumulative incidence of progression to occlusion was 4% at 1 year, 4% at 2 years, and 7% at 3 years. Progression of RAS occurred at an average rate of 7% per year for all categories of baseline disease combined. Progression of atherosclerotic RAS is relatively common, particularly from < 60% to ≥ 60% stenosis. Am J Hypertens 1996;9:1055–1061
PURPOSE:B-mode imaging of a normal arterial wall shows two echo-dense lines separated by an echolucent zone. Immediately after carotid endarterectomy, this double-line pattern is no longer detectable, but it subsequently reappears in some patients. The objective of this study was to test the hypothesis that the postoperative double line is associated with a lower incidence of carotid restenosis. METHODS:Carotid arteries were serially studied with B-mode ultrasound imaging at 2 weeks and 1, 2, 3, 6, 9, 12, 18, and 24 months after carotid endarterectomy. The wall of the common carotid artery 1 to 2 cm distal to the proximal endarterectomized shelf was analyzed for the presence, quality, and thickness of double lines. All hemodynamically significant stenoses (> or = 50% diameter reducing) were documented with standard duplex scanning criteria. RESULTS:Twenty-four carotid arteries in 23 patients were studied for a mean of 14.7 months (range, 3 to 24 months). A double line developed in 21 common carotid arteries (87.5%) at a mean time of 3.2 months (range, 0.5 to 9.0 months) after surgery with a mean thickness of 0.65 mm (SD = 0.17 mm) at the time of initial detection. A single hemodynamically significant stenosis developed in this group. All three of the remaining arteries that did not form the double-line pattern developed hemodynamically significant stenoses. Carotid restenosis was more likely to occur in arteries that did not form double lines (p < 0.05, Fisher's exact test). CONCLUSIONS:The majority of carotid arteries re-form a double line after endarterectomy. These arteries are less likely to develop restenotic lesions caused by myointimal hyperplasia.